Advertisement

Clinical Research in Cardiology

, Volume 97, Issue 1, pp 56–60 | Cite as

Ventricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and betablocker therapy

  • Herbert NägeleEmail author
  • S. Behrens
  • A. Castel
CLINICAL CORRESPONDENCE

Keywords

Acute Coronary Syndrome Amiodarone Dronedarone Brugada Syndrome Right Bundle Branch Block 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20:1391–1396PubMedCrossRefGoogle Scholar
  2. 2.
    Brugada J, Brugada P, Brugada R (1999) The syndrome of right bundle branch block, ST elevation in V1–V3 and sudden death: the Brugada syndrome. Europace 1:156–166PubMedCrossRefGoogle Scholar
  3. 3.
    Chinushi M, Furushima H, Tanabe Y, Washizuka T, Aizawaz Y (2005) Similarities between Brugada syndrome and ischemia-induced ST-segment elevation. Clinical correlation and synergy. J Electrocardiol 38(Suppl 4):18–21PubMedCrossRefGoogle Scholar
  4. 4.
    Aizawa Y, Sato A (2006) Brugada syndrome and vasospastic angina do coexist: potential clinical importance. Intern Med 45(2):43–44PubMedCrossRefGoogle Scholar
  5. 5.
    Yousef SE, Herre JM (2005) Brugada syndrome mimicking acute coronary syndrome. South Med J 98(8):817–821PubMedCrossRefGoogle Scholar
  6. 6.
    Paul G, Yusuf S, Sharma S (2006) Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion. Circulation 114:489–491CrossRefGoogle Scholar
  7. 7.
    Sheldon RS, Hill RJ, Cannon NJ, Duff HJ (1989) Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel. Circ Res 65:477–482PubMedGoogle Scholar
  8. 8.
    Lalevee N, Nargeot J, Barrere-Lemaire S, Gautier P, Richard S (2004) Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol 14:885–890CrossRefGoogle Scholar
  9. 9.
    Eleftheriadis D, Panagiotis V, Eleftheriadis N (2004) Recurrent syncopic episodes as a consequence of combined Brugada syndrome and paroxysmal atrial fibrillation. Which is the therapy of choice? Int J Cardiol 94(2–3):319–320PubMedCrossRefGoogle Scholar
  10. 10.
    Aouate P, Clerc J, Viard P, Seoud J (2005) Propranolol intoxication revealing a Brugada syndrome. J Cardiovasc Electrophysiol 16(3):348–351PubMedCrossRefGoogle Scholar
  11. 11.
    Ikeda T, Watanuki M, Masunaga N, Miyazawa T, Ninomiya T, Yamada M, Ohashi N, Matsui S (2007) Betablocker subscribed with antiarrhythmic drug for paroxysmal atrial fibrillation was suspected to associate with revealing Brugada syndrome and inducing ventricular fibrillation. Respiration and Circulation 55(4):473–477Google Scholar
  12. 12.
    Wilde A, Riera ARP, Shimizu W, Schulze-Bahr E, Tan H, Brugada P, Corrado D, Gussak I, LeMarec H, Nademanee K, Antzelevitch C, Brugada P, Borggrefe M, Brugada R endorsed by the Heart Rhythm Society and the European Heart Rhythm Association (2005) Brugada Syndrome. Report of the Second Consensus Conference. Circulation 111:659–670PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2008

Authors and Affiliations

  1. 1.St. AdolfstiftReinbek Medical DepartmentReinbekGermany
  2. 2.Hospital ClinicThorax Institute VillarroelBarcelonaSpain

Personalised recommendations